CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
to evaluate efficacy, safety and tolerability of treatment with zibotentan/dapagliflozin and dapagliflozin alone in participants with chronic kidney...
Phase 3
Austin, Texas, United States and 321 other locations
(for example heart attack and stroke) in people with cardiovascular disease, chronic kidney disease and inflammation.Parti...
Phase 3
San Marcos, Texas, United States and 943 other locations
The purpose of this study is to measure the efficacy and safety of baxdrostat/dapagliflozin in participants ≥ 18 years of age with CKD and HTN. This...
Phase 3
Austin, Texas, United States and 559 other locations
This study is to evaluate the efficacy and safety of PLS240 in patients with hemodialysis-dependent end stage kidney disease (ESKD)...
Phase 3
Austin, Texas, United States and 67 other locations
The researchers are doing this study to see if semaglutide can slow down the growth and worsening of chronic kidney disease in peop...
Phase 3
Austin, Texas, United States and 405 other locations
of serious heart-related complications or prevent the worsening of kidney function. The trial will enroll adults with body mass index 27 kg/ ...
Phase 3
Austin, Texas, United States and 348 other locations
This is a prospective, randomized, multi-center clinical trial for chronic kidney disease (CKD) patients referred for creation of a...
Austin, Texas, United States of America and 6 other locations
of KBP-5074 in adult participants who have stage 3b/4 chronic kidney disease (CKD) (estimated glomerular filtration rate [eGFR] cal ...
Phase 3
Austin, Texas, United States and 215 other locations
The objective of this study is to establish that the MB-102 transdermal fluorescence-measured Glomerular Filtration Rate (GFR) using the MediBeacon®...
Phase 3
Austin, Texas, United States and 4 other locations
or more. People can take part if they have cardiovascular or chronic kidney disease. People who have at least 2 health problems rel...
Phase 3
Austin, Texas, United States and 491 other locations
Clinical trials
Research sites
Resources
Legal